← All trials
NCT03106363
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 4, 2017
- Primary completion
- Jan 17, 2020
- Completion date
- Jan 17, 2020
- First posted
- Apr 10, 2017
- Last posted
- Feb 10, 2020
- Enrollment
- 85
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TorontoLead sponsor
- Canadian Institutes of Health Research (CIHR)Collaborator
- University of TorontoOverall official - principal investigator
- University of TorontoReponsible party - principal investigator
- Health CanadaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.